Subscribe To
BLCM / Is Bellicum Pharmaceuticals (BLCM) Outperforming Other Medical Stocks This Year?
BLCM News
By Zacks Investment Research
March 16, 2023
Bellicum (BLCM) Down on Ending Development of CAR-T Candidates
Following the decision to discontinue the development of pipeline candidates, Bellicum Pharmaceuticals (BLCM) is left with no candidate in clinical de more_horizontal
By Zacks Investment Research
February 27, 2023
Is Bellicum Pharmaceuticals (BLCM) Outperforming Other Medical Stocks This Year?
Here is how Bellicum Pharmaceuticals (BLCM) and Castle Biosciences, Inc. (CSTL) have performed compared to their sector so far this year. more_horizontal